The Application Tracker aims to help people keep up to date with pharmaceutical funding applications PHARMAC is considering. New applications are added as we receive them.
The Application Tracker includes all applications received since 2008, and most applications received since 2002. Click to show/hide the remaining applications.
The following applications are not visible in the Application Tracker. All of them were received before 2008. Several have been superseded by later applications.
|Trade (chemical) names||Date Received||Presentation||Applicant|
|Durex Avanti (non-latex male condoms)||September 2002||Packs of 5||Durex/SSL International Plc|
|Glucoval testing strips (blood glucose testing strips)||April 2003||AFT Pharmaceuticals|
|Cubitan||May 2003||Oral Supplements (200ml pack)||Nutricia|
|Taxanes||April 2004||Paclitaxel - 100 mg injection and 6 mg/ml solution for infusion. Docetaxel - 20mg and 80 mg injection and 20 mg / 0.5 ml and 40 mg/ml solution||Clinicians|
|Paroxetine Mesylate||April 2004||20mg||AFT Pharmaceuticals|
|MabThera (Rituximab)||June 2004||Single-use vials of 100 mg / 10ml and 500 mg / 50ml solution||Clinicians|
|Oxaliplatin||July 2004||Vials (50 mg and 100 mg)||Sanofi-Synthelabo|
|Xeloda (capecitabine)||May 2005||150mg, 500mg tablets (widening access)||Roche Products (NZ) Limited|
|Symbicort (budesonide with efomoterol)||July 2005||Dry Powder Inhaler 100/6 mcg, 200/6 mcg||AstraZeneca|
|Enlive plus||January 2006||Juice Style Adult oral supplement||Abbott Nutrition|
The Application Tracker tells you the key steps an application has been through, and also links you to relevant published PTAC minutes, subcommittee minutes, consultation letters, and related notifications.
You can search for applications by:
- Chemical Name
- Brand Name
- Therapeutic Group, e.g. "Oncology and Immunosuppressants", "Special Foods"
- The condition funding is requested for